Live-cell imaging revealed longer time-to-killing of TP53-mutant than wild-type TP53 AML cells upon attack by CAR T-cells, which ultimately led to an inability of CAR T-cells to control TP53-mutant cells. This evidence concerns the gene TP53 and acute myeloid leukemia.